C12Y 301/04045
N-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase
Official title: N-Acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (3.1.4.45)
C12Y301/04045 (N-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase) appears on 10 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 10
- Published applications
- 8
- Assignees
- 5
- Inventors
- 4
- Latest grant
- 15 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 4 | 1 |
| 2004 | 2 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Gene therapy for mucopolysaccharidosis IIIB15 Aug 2023US 11,723,989 B2The Trustees of the University of Pennsylvania
- GlcNAc phosphotransferase of the lysosomal targeting pathway13 May 2008US 7,371,366 B2Genzyme Corporation
- GIcNAc phosphotransferase of the lysosomal targeting pathway27 Jun 2006US 7,067,127 B2Genzyme Glycobiology Research Institute, Inc.
- Methods for producing highly phosphorylated lysosomal hydrolases1 Mar 2005US 6,861,242 B2Genzyme Glycobiology Research Institute, Inc.
- Phosphodiester α-GlcNAcase of the lysosomal targeting pathway7 Dec 2004US 6,828,135 B2Genzyme Glycobiology Research Institute, Inc.
- Gene therapy for mucopolysaccharidosis iiib11 Jan 2024US 2024/0009327 A1The Trustees of the University of Pennsylvania
- Gene therapy for mucopolysaccharidosis iiib17 Sep 2020US 2020/0289675 A1The Trustees of the University of Pennsylvania
- Glcnac phosphotransferase of the lysosomal targeting pathway24 Jul 2008US 2008/0176285 A1Genzyme Glycobiology Research Institute, Inc.
- GlcNAc phosphotransferase of the lysosomal targeting pathway6 Apr 2006US 2006/0073498 A1Genzyme Glycobiology Research Institute, Inc.
- GlcNac phosphotransferase of the lysosomal targeting pathway28 Apr 2005US 2005/0089869 A1Genzyme Glycobiology Research
Most cited
By later US patents
- Methods of treating lysosomal storage diseases126US 6,537,785 B1Genzyme Glycobiology Research Institute, Inc. · 2003
- Methods for producing highly phosphorylated lysosomal hydrolases86US 6,534,300 B1Genzyme Glycobiology Research Institute, Inc. · 2003
- Methods for producing highly phosphorylated lysosomal hydrolases50US 6,670,165 B2Genzyme Glycobiology Research Institute, Inc. · 2003
- GlcNAc phosphotransferase of the lysosomal targeting pathway34US 6,642,038 B1Genzyme Glycobiology Research Institute, Inc. · 2003
- Phosphodiester-a-GlcNAcase of the lysosomal targeting pathway31US 6,770,468 B1Genzyme Glycobiology Research Institute, Inc. · 2004